http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017215151-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91ce16ac3dbceb38cb5e6983c8c15a5a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate | 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eec11735c40ab96617eff118b2d956f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca0da7f5d466ccdcd7070bb6fbac7a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f6ff59ef0c3002d3d60089e069fb5d |
publicationDate | 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2017215151-A |
titleOfInvention | Renal cell carcinoma marker and use thereof |
abstract | A novel renal cell carcinoma marker is provided. A renal cell carcinoma marker comprising a Serine / threonine-protein kinase grease wall (MASTL) protein or a MASTL gene. A diagnostic agent for renal cell cancer comprising a specific binding substance for MASTL protein, a primer set capable of amplifying MASTL gene, or a probe that specifically hybridizes to mRNA of MASTL gene. When the amount of MASTL protein present in the biological sample is measured and the amount of MASTL protein measured is greater than that of the control, it is determined that the biological sample is derived from a renal cell carcinoma patient And a biological sample determination method comprising: a step. [Selection figure] None |
priorityDate | 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.